HealthBeacon, a Dublin-based medical technology company that plans to float on the stock market with a valuation of €100 million, had revenues of €1.2 million in 2020 and recorded a loss from continuing operations of €3.4 million. The company, however, is predicting that it is on the brink of growing explosively from 4,585 units deployed in 2020 to 100,000 by the end of 2023. HealthBeacon has developed a solution that helps patients better adhere to injectable medications schedules across seven therapeutic areas such as respiratory, rheumatology, and neurology. It is selling 25 per cent of its shares to raise €25…

Join The Currency

Sign up today: Full annual membership for just €200.

Don’t miss out on what is going on with our daily unique stories from our team of skilled journalists and insightful commentators.

Members of The Currency get full access to over 2,500 exclusive interviews, investigations, and analysis, plus over 180 podcasts.

Annual membership is just €200 for the first year, a saving of €100.

Or try The Currency for the first month for a special introductory rate of €5, a saving of €20.

Cancel at any time.

To become a member today click here.